Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT00404872 · ClinicalTrials.gov registry record
Evaluating the Relationship Between Fatty Acids and Heart Disease
A clinical trial, sponsored by Brigham and Women's Hospital.
- Completed
- Registry status
- 4,766
- Enrollment target
NCT00404872: Completed study, sponsored by Brigham and Women's Hospital.
NCT00404872 is a clinical trial that has completed, run by Brigham and Women's Hospital. The registered enrollment target is 4,766 participants. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT00404872 has completed, sponsored by Brigham and Women's Hospital.
- COMPLETED
- Registry status
- 4,766 participants
- Enrollment target
Study Summary
Cardiovascular disease (CVD) affects millions of people in the United States; each year, more people die from CVD than from any other disease. Individuals with low levels of n-3 fatty acids and high levels of trans-fatty acids may have an increased risk of developing CVD. This study will evaluate the link between fatty acids and the presence of CVD in older adults.
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 4,766 participants |
| Start Date | 1989-01 |
| Est. Completion | 2006-06 |
What the finished NCT00404872 record still lists
NCT00404872 is an observational study that tracks outcomes without assigning an intervention. Its 4,766 participants enrollment target places it among the larger protocols in the corpus.
The record links to 0 conditions, and to 0 interventions.
NCT00404872 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT00404872 about?
NCT00404872 is a clinical study titled "Evaluating the Relationship Between Fatty Acids and Heart Disease". Cardiovascular disease (CVD) affects millions of people in the United States; each year, more people die from CVD than from any other disease. Individuals with low levels of n-3 fatty acids and high levels of trans-fatty acids may have an increased risk of developing CVD. This study will evaluate th...
What is the current status of trial NCT00404872?
This trial is currently completed. The enrollment target is 4,766 participants. The study started on 1989-01. Estimated completion is 2006-06.
Who is sponsoring clinical trial NCT00404872?
This trial is sponsored by Brigham and Women's Hospital, which has 937 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT01719055 · 4,800 participants
RELIEF - A Global Prospective Observational Post-Market Study to Evaluate Long-Term Effectiveness of Neurostimulation Therapy for Pain
- NCT05485675 · 4,800 participants · NA
Stand & Move at Work II: Effectiveness and Implementation of a Worksite Wellness Program
- NCT06307652 · 4,800 participants · Phase 3
Study to Evaluate the Effect of Balcinrenone/Dapagliflozin in Patients With Heart Failure and Impaired Kidney Function
- NCT04371900 · 4,700 participants · NA
Michigan Contraceptive Access, Research, and Evaluation Study Children: Phase 1
Similar registry start date
- NCT05988463 · started 2027-01-01 · Phase 1
Dose-Escalation Study of Artesunate Patients With IPF
- NCT07219706 · started 2026-12-10 · NA
Dietary Fiber and Time Restricted Eating
- NCT02831335 · started 2026-12-01
Technical Development of Multi-Parametric Renocerebral MRI
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia